Real World Study of Platinum Containing Dual Drug Chemotherapy Followed by Large Fractionated Radiotherapy Combined withTislelizumab in Stage IIIB/C-IV Non-small Cell Lung Cancer Patient

Clinical trial NCT07198217 · RECRUITING

Trial details

NCT number: NCT07198217
Sponsor: Zibo Municipal Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC Tislelizumab Chemotherapy Hypofractionated Radiotherapy

Start date: 2021-05-25
Primary completion: 2025-09-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.